Maximal serological diagnosis of cryptococcosis may be accomplished through the concurrent use of three tests: the latex agglutination (LA) test for cryptococcal antigen, and the indirect fluorescent antibody (IFA) and tube agglutination (TA) tests for Cryptococcus neoformans antibodies. These tests were applied to 141 serum and cerebral spinal fluid specimens from 66 culturally proven cases of cryptococcosis and to 42 sera from normal subjects and from patients with other systemic mycotic diseases. The LA test was sensitive and completely specific; of the sera from proven cases, 55% were positive. With the TA test, 37% of the specimens were positive and the test was highly specific. With the IFA test, 38% of the specimens were positive and the test appears to be the least specific of the three. Cross-reactions were most evident with blastomycosis and histoplasmosis case sera. When the three tests were used concurrently, 87% of the cryptococcosis case specimens were positive and permitted a presumptive diagnosis of C. neoformans infections in 61 (92%) of the 66 patients whose specimens were examined.
Cryptococcosis is a pulmonary disease that frequently spreads to other parts of the body, particularly the central nervous system. Clinically, it may be confused with other infectious and malignant diseases. The diagnosis of cryptococcosis may be difficult because Cryptococcus neofornans is an opportunist which readily coexists with malignant diseases of the reticuloendothelial and lymphatic systems, diabetes, histoplasmosis, and tuberculosis. Furthermore it is often implicated as a secondary invader when broad spectrum antibiotics, steroids, or cytotoxic agents are administered (3, 5, 6) .
The actual incidence of cryptococcosis is not known; however, various authorities estimate that the disease is more common than suspected. J. P. Utz estimated that 200 to 300 cases of cryptococcal meningitis occur annually in the United States (The Evening Star, Washington, D.C., 16 Nov. 1964 ). Littman and Schneierson (11) state that that 5,000 to 15,000 subclinical and clirmical pulmonary cases of cryptococcosis occur annually in New York City alone. Since 1952, the number of deaths reported due to C. neoformans within the United States has averaged 66 -per year (1) . The almost 100% mortality rate of' cryptococcal meningitis before the era of amphotericin B therapy (5) stresses the paramount need for accurate and rapid diagnosis of this disease and its control.
Until recently, individuals suffering from cryptococcosis were considered essentially immunologically inert. Consequently, diagnosis was limited to time-consuming cultural and biochemical procedures. Within the last few years, in response to the increased awareness of cryptococcal infections, a number of serologic procedures have been developed and reported. This study was undertaken to develop and evaluate new procedures and to evaluate the specificity and sensitivity of established ones.
MATERIALS AND METHODS
Serum and spinal fluid specimens. Specimens received in the Fungus Immunology Unit, NCDC, were from culturally proven cases of blastomycosis, candidiasis, coccidioidomycosis, cryptococcosis, and histoplasmosis and from apparently healthy humans. The clinical diagnosis in each case was obtained from t-he attending physician. All specimens were preserved with Merthiolate (1:10,000) and stored at -20 C.
Complement-fixation (CF) test. Sera and cerebral spinal fluids (CSF) were titrated for cryptococcal antibody and antigen by the Laboratory Branch Complement Fixation (LBCF) test (14) . This test involves five 50% units of complement in 0.4 ml in a total volume of 1.0 ml. The antigen-antibody-complement mixture is incubated for 15 to 18 hr at 4 C. The antigen used for detecting antibodies was a 10% suspension of whole cells of C. neoformans culture B-551 (8 (4) . Specimens of serum and spinal fluid were inactivated at 56 C for 30 min, and then serially diluted in pH 9 .0 glycinebuffered saline that contained 0.1% bovine serum albumin. Equal volumes of a spectrophotometrically standardized suspension of latex particles were mixed with the highest dilution of 4% rabbit C. neoformans antiglobulin giving a clear agglutination pattern with a reference serum containing cryptococcal polysaccharide. To perform the test, 0.04 ml of heat-inactivated serum or spinal fluid was placed in a corner of a 2.54-cm square of a paraffin-ruled glass slide. A 0.02-ml amount of the latex-globulin suspension was placed in the opposite corner. The reagents were mixed and agitated for 2 min on a rotary shaker at 100 rev/min. The antigen titer was recorded as the highest dilution of a serum or spinal fluid that showed agglutination equivalent to the positive control. All positive specimens were also tested with latex particles sensitized with normal rabbit globulin to rule, out false positives.
Tube agglutination (TA) tests. C. neoformans culture B551, a weakly encapsulated isolate, was used as an agglutinogen (8) . Agglutinin titers were determined by a tube test using 0.25 ml of antigen turbidimetrically adjusted to a no. 2 McFarland nephelometer standard. All sera were inactivated by heating at 56 C for 30 min. Twofold dilutions of each serum were made, beginning with an undiluted specimen. Readings were made after 2 hr of incubation at 37 C and overnight refrigeration at 4 C.
RESULTS
The relative sensitivity of the five serological tests for cryptococcal disease was initially determined with 49 serum and CSF specimens from 36 culturally proven cases of cryptococcosis. Of the 46 serum and 3 CSF specimens, 43 sera and all 3 CSF specimens were positive for antigen by the LA test (Table 1 Studies were undertaken to determine whether the cryptococcal IFA reactions could be more specifically interpreted if parallel IFA and CF tests were performed with H. capsulatum and B. dermatitidis antigens. The assumption was made that the cryptococcal antibody would not react with the heterologous antigens in the CF and IFA tests. Studies were performed with sera from human cases of blastomycosis, cryptococcosis, and histoplasmosis. The data obtained (Table 4) indicated that the IFA test was susceptible to nonspecific reactions. All of the IFA test antigens showed reactions with the heterologous antisera examined. The CF tests for histoplasmosis and blastomycosis were positive with many of the cryptococcosis case sera and were no more discerning than the IFA tests in diagnosing cryptococcosis.
No particular pattern of serological response could be correlated with any one clinical type of cryptococcosis. The IFA staining reactions varied from 2 to 4+ with the standard 1:20 dilution of serum, whereas the TA titers ranged from 1:2 to 1:20. Intense (4+) staining or high agglutinin titers, or both, were not indicative of severe cryptococcal infections. The LA titers varied from undiluted to 1:64,000. In contrast to high antibody titers, high antigen titers reflected progressive disease. Unlike the results of Walter and Jones (17) our studies indicated that the LA test was more sensitive than the CF test for detection of capsular polysaccharide in clinical materials. Of the 49 serum and CSF specimens from proven cases, 95% were positive with the LA test, 55% were positive with the CF test, and 30% were positive with the ID test. All specimens positive for antigen by the CF and ID tests were also positive with the LA procedure. The differences noted between the sensitivities of our tests for soluble antigens and those of the tests used by Walter and Jones (17) might be attributed to our modifications.
The ability to detect cryptococcal antibodies in proven case sera varied with the test used. The IFA test, as indicated by Vogel and Padula (16) , was the most sensitive procedure because the highest percentage of proven case sera were positive ( (17) . Recent studies with IFA tests both for cryptococcal antigens and for antibodies indicate that such tests provide presumptive evidence for cryptococcosis in approximately 90% of suspected cases (12) . Our studies (Table 2) indicate that the parallel use of LA, TA, and IFA tests permits the maximal sero-diagnosis of cryptococcosis. The application of this battery of tests to CSF or serum specimens, or both, from 66 proven cases permitted a presumptive diagnosis of cryptococcosis in 92% of the patients. No single test provided this level of sensitivity. Our studies also revealed that the LA test was the most useful for detecting cryptococcal meningitis (Table 2) . Of the 21 proven case CSF specimens, 71 % were positive when the LA test was used, in contrast to less than 0.5% with the TA test and none with the IFA tests for antibody.
In routine applications of the three tests, less than 8% of the sera from proven cases were negative (Table 2) . A diagnosis of cryptococcosis should not be excluded on the basis of negative serology. Intensive cultural and biochemical studies are advised in cases in which clinical symptoms are consistent with cryptococcosis and no etiology has been established.
Of the three tests extensively evaluated, the most specific was the LA test ( (17) , were sometimes observed after the initial diagnosis was made and even after administration of antiboitics. With extensive chemotherapy, the antigen titer tended either to decline to a low level or become negative (Table 5) .
At the time of admission, some patients demonstrated only antibody, some only antigen, and others both substances in various body fluids. For early, accurate diagnosis of cryptococcosis, all three serological tests must be performed for the detection of cryptococcal antigens or antibodies, or both.
